Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Bone Pain Treatment Companies

ID: MRFR/Pharma/1241-HCR
80 Pages
Satyendra Maurya
Last Updated: February 16, 2025
The treatment of bone pain can involve a variety of approaches, including pharmaceuticals, medical devices, and therapies. Several companies are involved in the development and production of medications and devices aimed at addressing bone pain associated with conditions such as fractures, osteoporosis, or cancer.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Bone Pain Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.49%
2024 Market Size$ 7.09 Billion
2025 Market Size$ 7.55 Billion
2035 Market Size$ 14.16 Billion
Key Players
Pfizer
Johnson & Johnson
Novartis
Bristol-Myers Squibb
Amgen
AbbVie
Opportunities
  • Government Initiatives and Funding
  • Advancements in Pharmaceutical Research
  • Increasing Prevalence of Bone Disorders

Top Industry Leaders in the Bone Pain Treatment Market

Bone Pain Treatment Companies
 

Latest Bone Pain Treatment Companies Updates:

Eli Lilly and Company (US) Announced positive Phase 3 data for its tanezumab antibody drug for osteoarthritis pain, potentially offering a longer-lasting alternative to opioids (August 2023).

Amgen Received FDA approval for its Evenity™ (romosozumab) injection for the treatment of osteoporosis in postmenopausal women at high risk for fracture (September 2023).

Medtronic plc (Ireland) Launched its Intellis™ Spinal Cord Stimulation System with advanced features for personalized pain relief in chronic back and leg pain (October 2023).

Baxter International Received CE Mark approval for its Mobi-C™ vertebral augmentation system for minimally invasive treatment of painful vertebral compression fractures (November 2023).

Regeneron Pharmaceuticals Partnered with Bone Therapeutics to develop and commercialize bone anabolic therapy for osteoporosis patients (December 2023).

List of Bone Pain Treatment Key companies in the market:

  • Eli Lilly
  • Amneal Pharmaceuticals LLC.
  • Actavis plc
  • Novartis International AG
  • Marksans Pharma
  • Amgen, Inc.
  • Debiopharm Group
  • Pfizer, Inc.
  • Eli Lilly
  • Boston Scientific
  • Venus Remedies Ltd.